Form D — Cognos Therapeutics Inc
0001651490-26-000003 · filed Jul 2, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,000,000
- Reported amount sold
- $250,000
- Minimum investment
- $10,000
- Investors
- 0
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Cognos Therapeutics Inc
- CIK
- 1651490
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 10604 S. LA CIENEGA BLVD.
INGLEWOOD, CA 90304 - Phone
- (310) 641-2700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Frank Adell · Executive OfficerInglewood, CA Find on LinkedIn ↗
-
Thomas Chen · DirectorInglewood, CA Find on LinkedIn ↗
-
Eli Gang · DirectorInglewood, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗